Identification of prostate cancer modifier pathways using parental strain expression mapping
暂无分享,去创建一个
Todd R Golub | William R Sellers | Massimo Loda | T. Golub | K. Ross | M. Loda | W. Sellers | P. Majumder | Qing Xu | Pradip K Majumder | Kenneth Ross | Yeonju Shim | Qing Xu | Yeonju Shim
[1] D. Pinkel,et al. MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma , 2006, Science.
[2] N. Risch. Searching for genetic determinants in the new millennium , 2000, Nature.
[3] R. Stoughton,et al. Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.
[4] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[6] W. Hong,et al. Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] T. Poggio,et al. Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[9] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[10] T. Golub,et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways , 2004, Nature Medicine.
[11] T. Golub,et al. A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.
[12] Todd R. Golub,et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] William Valdar,et al. Strategies for mapping and cloning quantitative trait genes in rodents , 2005, Nature Reviews Genetics.
[15] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Simon,et al. Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27 , 2005, Molecular and Cellular Biology.
[17] W. Zwerschke,et al. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. , 2003, The Biochemical journal.
[18] E. Cuppen. Haplotype-based genetics in mice and rats. , 2005, Trends in genetics : TIG.
[19] A. Darvasi,et al. Complexities in the genetic dissection of quantitative trait loci. , 2002, Trends in genetics : TIG.
[20] E. Lander,et al. Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.
[21] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[22] M. Meyerson,et al. EGFR gene mutations: a call for global x global views of cancer. , 2005, Journal of the National Cancer Institute.
[23] J. Gray,et al. The genetics and genomics of cancer , 2003, Nature Genetics.
[24] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[25] M. Becich,et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.